{"abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the following virtual public meeting entitled \"Animal Generic Drug User Fee Act.\" The purpose of the public meeting is to invite public comment on the Animal Generic Drug User Fee Act (AGDUFA) program and suggestions regarding the features FDA should consider for the next reauthorization of the AGDUFA program. The meeting will be open to the public.","action":"Notice of public meeting; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/04/17/2026-07497.html","cfr_references":[],"citation":"91 FR 20691","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The public meeting will be held virtually on May 27, 2026, from 11 a.m. to 1 p.m. Eastern Time. See the SUPPLEMENTARY INFORMATION section for registration dates and information. To permit the widest possible opportunity to obtain comments on all aspects of the public meeting, the docket will remain open for comment throughout the reauthorization process of AGDUFA, until December 1, 2027. In addition to being publicly viewable at http://www.regulations.gov, comments received by July 1, 2026, suggesting changes to the program, will also be published on https://www.fda.gov/industry/animal-generic-drug-user- fee-act-agdufa/agdufa-meetings.","disposition_notes":null,"docket_ids":["Docket No. FDA-2011-N-0655"],"dockets":[],"document_number":"2026-07497","effective_on":null,"end_page":20693,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/04/17/2026-07497.xml","html_url":"https://www.federalregister.gov/documents/2026/04/17/2026-07497/animal-generic-drug-user-fee-act-public-meeting-request-for-comments","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-07497?publication_date=2026-04-17","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-04-17/2026-07497/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":28,"last_updated":"2026-04-17 10:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-17/pdf/2026-07497.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-07497.pdf?1776343510","publication_date":"2026-04-17","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/04/17/2026-07497.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2026-04-17T05:07:49Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":20691,"subtype":null,"title":"Animal Generic Drug User Fee Act; Public Meeting; Request for Comments","toc_doc":"Animal Generic Drug User Fee Act","toc_subject":"Hearings, Meetings, Proceedings, etc.","topics":[],"type":"Notice","volume":91}